Market News & Trends
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
Annovis Bio Inc. recently announced the filing of the new composition of matter patent with the US Patent and Trademark Office covering novel solid forms…
Silo Pharma Partners With AmplifyBio to Advance SPC-15 for PTSD & Anxiety
Silo Pharma, Inc. recently announced it has awarded a contract to its contract research organization (CRO) partner AmplifyBio for an investigational new drug (IND)-enabling large…
Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder
Nexalin Technology, Inc. recently announced positive results of a clinical study designed to evaluate the feasibility, safety, and efficacy of transcranial alternating current dynamic frequency stimulation…
IGC Pharma's Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease
IGC Pharma, Inc. recently announced encouraging preclinical results in an Alzheimer’s mouse model demonstrating the potential of the company’s therapeutic candidate, TGR-63, to combat Alzheimer's…
Emmes Partners With ILiAD Biotechnologies to Conduct Phase 3 Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine
ILiAD Biotechnologies, LLC recently announced the selection of Emmes Group, a global contract research and technology organization, to conduct upcoming Phase 3 studies of its lead…
Immutep Signs Exclusive License Agreement With Cardiff University for Next-Generation Anti-LAG-3 Molecules for Cancer
Immutep Limited recently announced a license agreement with Cardiff University granting the company exclusive rights to develop and commercialize anti-LAG-3 small molecules. A number of…
Ethris Announces Positive Initial Phase 1 Data Demonstrating Nasal Delivery of mRNA Lead Candidate
Ethris GmbH recently announced preliminary positive data from its Phase 1 dose escalation clinical trial evaluating the safety, tolerability, and target engagement of lead mRNA…
Kane Biotech Signs Worldwide License Agreement With I-MED Pharma
Kane Biotech Inc. recently announced it has entered into a worldwide license agreement with I-MED Pharma Inc. for the DispersinB technology. Biofilm is a known…
SPT Labtech & Olink Announce New Automated Solution to Accelerate Research With Olink Next-Generation Proteomics Technology
SPT Labtech and Olink Holding AB recently announced the introduction of an additional automation option for the Olink Explore HT protocol for high-throughput proteomics with SPT Labtech’s…
Qure.ai Announces Strategic Investment by Merck Global Health Innovation Fund
Merck Global Health Innovation Fund has made a strategic investment into Qure.ai as part of its Series D round. This funding will go towards investing…
Superlab Suisse Opens State-of-the-Art Facility, Fostering New Spaces for Scientific Breakthroughs
For life sciences and biotech companies, access to affordable dedicated lab spaces is hard to come by. Labs are prohibitively expensive to build and operate,…
Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery & Development of Therapies
Thermo Fisher Scientific Inc. recently introduced the Thermo Scientific KingFisher PlasmidPro Maxi Processor (PlasmidPro), the only fully automated maxi-scale plasmid DNA (pDNA) purification system. PlasmidPro…
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione recently announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon. The new line is the result of the…
CoreRx Completes Acquisition of Societal CDMO
CoreRx, Inc. recently announced it has completed its acquisition of Societal CDMO, Inc. a contract development and manufacturing organization dedicated to solving complex formulation and…
Skinvisible Expands Obesity Patent Application for Transdermal Delivery
Skinvisible Pharmaceuticals, Inc. recently announced the filing of a second patent application for its groundbreaking Invisicare technology and its transdermal delivery of obesity and glucose-controlling…
BioNTech & DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate in Prostate Cancer
BioNTech SE and Duality Biologics recently announced the US FDA granted Fast Track designation for BNT324/DB-1311 for the treatment of patients with advanced/unresectable, or metastatic…
TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder Clinical Program for the Prevention of Lung Transplant Rejection
TFF Pharmaceuticals, Inc. recently announced a regulatory update on its TFF TAC clinical program following its recent interaction with the US FDA. In April 2024,…
Checkpoint Therapeutics Announces Alignment With FDA Enabling Upcoming Cosibelimab BLA Resubmission
Checkpoint Therapeutics, Inc. recently announced it has reached alignment with the US FDA on its biologics license application (BLA) resubmission strategy for cosibelimab. Accordingly, Checkpoint…
4DMT Announces FDA Clearance of IND Application for Genetic Medicine for the Treatment of Geographic Atrophy
4D Molecular Therapeutics recently announced the US FDA clearance of the Investigational New Drug Application (IND) for 4D-175, an R100 vector-based intravitreal genetic medicine, for…
IMUNON Announces Database Lock for Phase 2 OVATION 2 Study With IMNN-001 in Advanced Ovarian Cancer
IMUNON, Inc. recently announcef database lock for its Phase 2 OVATION 2 Study evaluating the safety and efficacy of IMNN-001 in patients with advanced ovarian…
